DE2826075C2 - - Google Patents

Info

Publication number
DE2826075C2
DE2826075C2 DE2826075A DE2826075A DE2826075C2 DE 2826075 C2 DE2826075 C2 DE 2826075C2 DE 2826075 A DE2826075 A DE 2826075A DE 2826075 A DE2826075 A DE 2826075A DE 2826075 C2 DE2826075 C2 DE 2826075C2
Authority
DE
Germany
Prior art keywords
cells
antibodies
mice
virus
hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2826075A
Other languages
German (de)
English (en)
Other versions
DE2826075A1 (de
Inventor
Hilary Prof. Wynnewood Pa. Us Koprowski
Walter U. Prof. Gerhard
Carlo M. Prof. Philadelphia Pa. Us Croce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of DE2826075A1 publication Critical patent/DE2826075A1/de
Application granted granted Critical
Publication of DE2826075C2 publication Critical patent/DE2826075C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19782826075 1977-06-15 1978-06-14 Verfahren zur produktion von antikoerpern Granted DE2826075A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80685777A 1977-06-15 1977-06-15

Publications (2)

Publication Number Publication Date
DE2826075A1 DE2826075A1 (de) 1979-02-15
DE2826075C2 true DE2826075C2 (enExample) 1987-08-06

Family

ID=25194989

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782826075 Granted DE2826075A1 (de) 1977-06-15 1978-06-14 Verfahren zur produktion von antikoerpern

Country Status (19)

Country Link
JP (2) JPS592276B2 (enExample)
AU (1) AU525724B2 (enExample)
BE (1) BE868099A (enExample)
CA (1) CA1103157A (enExample)
CH (1) CH640735A5 (enExample)
DE (1) DE2826075A1 (enExample)
DK (1) DK267378A (enExample)
ES (1) ES470729A1 (enExample)
FI (1) FI64952C (enExample)
FR (1) FR2394607A1 (enExample)
GB (1) GB2000186A (enExample)
IL (1) IL54908A (enExample)
IT (1) IT1096742B (enExample)
LU (1) LU79812A1 (enExample)
NL (1) NL7806471A (enExample)
NO (1) NO782081L (enExample)
PL (1) PL207652A1 (enExample)
SE (1) SE7806729L (enExample)
ZA (1) ZA783261B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963410D1 (en) 1978-08-10 1982-09-16 Schering Ag Process for obtaining murine immunglobulin-e antibodies, hybrid cell lines used in the process and the process for preparing them, application of the immunglobulin-e antibodies so obtained
CA1142466A (en) * 1979-01-09 1983-03-08 National Research Development Corporation Cell lines
US4271145A (en) * 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US5204095A (en) * 1980-04-09 1993-04-20 National Research Development Corporation Monoclonal antibodies against hepatitis B virus
EP0038642B1 (en) * 1980-04-09 1989-02-08 National Research Development Corporation A monoclonal antibody against hepatitis b and its production, a hybridoma producing the monoclonal antibody and compositions containing it, the propagation of the hybridoma and the monoclonal antibody for use as an antiviral agent against hepatitus b and in isolating hepatitus b surface antigen from a sample
NL185309C (nl) * 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
AU567693B2 (en) * 1982-09-30 1987-12-03 University Of Rochester Human monoclonal antibodies against bacterial toxins
JPH03271235A (ja) * 1983-04-08 1991-12-03 Kureha Chem Ind Co Ltd 抗カンジダ菌抗体分泌ハイブリドーマ
JPS60104020A (ja) * 1983-10-14 1985-06-08 メルク　エンド　カムパニー　インコーポレーテツド Ａ型肝炎‐タンパク質サブユニツト抗原
US4707442A (en) * 1983-10-24 1987-11-17 Board Of Regents, The University Of Texas System Hybrid cell line producing monoclonal antibody cytolytic to Trichomonas vaginalis
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
NL8401221A (nl) * 1984-04-16 1985-11-18 Innovi Nv Analytische toepassing van fagocyt-cellijnen.
JPS6140800A (ja) * 1984-07-27 1986-02-27 バイオテクノロジー　アンド　エクスペリメンタル　リサーチ　インコーポレーテツド 電気細胞融合法を用いたモノクローナル抗体の製造方法
WO1986002092A1 (fr) * 1984-09-28 1986-04-10 Teijin Limited Hybridome homme-souris produisant un anticorps humain antiviral, procede de preparation et anticorps monoclonal humain antiviral
JPS6181782A (ja) * 1984-09-28 1986-04-25 Teijin Ltd 抗ウイルス・ヒト抗体を産生するマウス−ヒトハイブリド−マ及びその製造法並びにその使用方法
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
JPS61104796A (ja) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体の製造方法
JP2518607B2 (ja) * 1985-08-29 1996-07-24 雪印乳業株式会社 インフルエンザａ型ウイルスｈａ抗原に対するモノクロ―ナル抗体およびその作成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof

Also Published As

Publication number Publication date
FI64952C (fi) 1984-02-10
FI781818A7 (fi) 1978-12-16
IL54908A (en) 1982-01-31
ZA783261B (en) 1979-06-27
IL54908A0 (en) 1978-08-31
IT1096742B (it) 1985-08-26
AU3708878A (en) 1979-12-20
FI64952B (fi) 1983-10-31
JPS5417185A (en) 1979-02-08
CH640735A5 (de) 1984-01-31
CA1103157A (en) 1981-06-16
PL207652A1 (pl) 1979-06-04
NO782081L (no) 1978-12-15
DE2826075A1 (de) 1979-02-15
AU525724B2 (en) 1982-11-25
DK267378A (da) 1978-12-16
JPS592276B2 (ja) 1984-01-18
ES470729A1 (es) 1979-01-16
GB2000186A (en) 1979-01-04
FR2394607A1 (fr) 1979-01-12
JPS58101688A (ja) 1983-06-16
BE868099A (fr) 1978-10-02
IT7824577A0 (it) 1978-06-14
FR2394607B1 (enExample) 1983-12-30
LU79812A1 (de) 1978-12-07
NL7806471A (nl) 1978-12-19
SE7806729L (sv) 1978-12-16

Similar Documents

Publication Publication Date Title
US4196265A (en) Method of producing antibodies
CH640735A5 (de) Verfahren zum herstellen von virusantikoerpern.
DE3853779T2 (de) Hiv-1 neutralisierende monoklonale antikörper.
DE3301249C2 (enExample)
DE3853210T2 (de) Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion.
DE3001585C2 (de) Verfahren zur Herstellung von Interferon Typ I und II
DE69126526T2 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
AT398080B (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
DE3650032T2 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
EP0445625A1 (de) Humane monoklonale Antikörper gegen Tollwutviren, ihre Herstellung und Verwendung
DE69738312T2 (de) Hepatitis b monoklonale antikörper
DE3144181A1 (de) "human-myelomazell-linie und verfahren zur herstellung einer hybridzell-linie"
DE69005908T2 (de) Monoklonale Antikörper zur Behandlung nach einem Kontakt mit Tollwutvirus.
DE69529272T2 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
DE3689948T2 (de) Monoklonale antikörper und testverfahren.
DE69323130T2 (de) Avirulenter Tollwut-Impfstoff
DE3854267T2 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
DE3752184T2 (de) Herstellung und Verwendungen von gamma-Interferon
AT503297A4 (de) Allergen-spezifische antikörper
DE3787239T2 (de) Komplementabhängiger zytolytischer monoklonaler Antikörper gegen Trichomonas vaginalis und seine therapeutische und diagnostische Verwendung.
EP3873526B1 (en) Anti-rabies monoclonal antibodies and cocktail thereof
DE69025629T2 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DE68907280T2 (de) Avirulenter Tollwut-Impfstoff.
EP0210552B1 (de) Tollwut-Lebendimpfstoff
DE68926813T2 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8363 Opposition against the patent
8331 Complete revocation